文献
J-GLOBAL ID:200902279623991152
整理番号:09A0327680
可溶性インターロイキン-2受容体はリツキシマブプラスCHOP(RCHOP)治療を受けたびまん性大細胞型B細胞リンパ腫患者で予後価値を保持する
Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy
著者 (13件):
ENNISHI D.
(Cancer Inst. Hospital, Tokyo)
,
ENNISHI D.
(Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sci., Okayama)
,
YOKOYAMA M.
(Cancer Inst. Hospital, Tokyo)
,
TERUI Y.
(Cancer Inst. Hospital, Tokyo)
,
ASAI H.
(Cancer Inst. Hospital, Tokyo)
,
SAKAJIRI S.
(Cancer Inst. Hospital, Tokyo)
,
MISHIMA Y.
(Cancer Inst. Hospital, Tokyo)
,
TAKAHASHI S.
(Cancer Inst. Hospital, Tokyo)
,
KOMATSU H.
(Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sci., Okayama)
,
IKEDA K.
(Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sci., Okayama)
,
TAKEUCHI K.
(Japanese Foundation for Cancer Res., Tokyo)
,
TANIMOTO M.
(Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sci., Okayama, JPN)
,
HATAKE K.
(Cancer Inst. Hospital, Tokyo)
資料名:
Annals of Oncology
(Annals of Oncology)
巻:
20
号:
3
ページ:
526-533
発行年:
2009年03月
JST資料番号:
W0107A
ISSN:
0923-7534
CODEN:
ANONE2
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)